Ticker

BBIO

BridgeBio Pharma, Inc.

17 catalysts on file

BBIO

BridgeBio Pharma, Inc.

Phase 3 Confirmed

infigratinib

achondroplasia

190d ago Feb 12, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 3 AI-extracted

acoramidis

transthyretin amyloid cardiomyopathy (ATTR-CM)

182d ago Feb 20, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

PDUFA AI-extracted

BBP-418

limb-girdle muscular dystrophy type 2I/R9

147d ago Mar 27, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 2 AI-extracted

acoramidis

transthyretin amyloid cardiomyopathy (ATTR-CM)

109d ago May 4, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Approval AI-extracted

acoramidis

transthyretin amyloid cardiomyopathy (ATTR-CM)

109d ago May 4, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 2 AI-extracted

encaleret

autosomal dominant hypocalcemia type 1 (ADH1)

101d ago ~ May 12, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 3 AI-extracted

encaleret

chronic hypoparathyroidism

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 3 Confirmed

BBP-418

limb-girdle muscular dystrophy type 2I/R9

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

PDUFA AI-extracted

encaleret

autosomal dominant hypocalcemia type 1 (ADH1)

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

PDUFA AI-extracted

infigratinib

achondroplasia

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Catalyst AI-extracted

infigratinib

achondroplasia

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

CRL AI-extracted

encaleret

autosomal dominant hypocalcemia type 1 (ADH1)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

CRL AI-extracted

infigratinib

achondroplasia

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Phase 2 AI-extracted

infigratinib

hypochondroplasia

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Approval AI-extracted

encaleret

chronic hypoparathyroidism

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Approval AI-extracted

infigratinib

achondroplasia

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

BBIO

BridgeBio Pharma, Inc.

Approval AI-extracted

BBP-418

LGMD2I/R9

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →